Linc (6ZB) Stock Overview
A private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6ZB from our risk checks.
6ZB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Linc AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 6.62 |
| 52 Week High | SEK 7.25 |
| 52 Week Low | SEK 5.52 |
| Beta | 0.69 |
| 1 Month Change | 8.35% |
| 3 Month Change | -0.60% |
| 1 Year Change | 1.07% |
| 3 Year Change | 24.20% |
| 5 Year Change | -34.97% |
| Change since IPO | -36.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6ZB | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | 3.9% | -1.2% | 0.1% |
| 1Y | 1.1% | 10.9% | -0.5% |
Return vs Industry: 6ZB underperformed the German Capital Markets industry which returned 11.3% over the past year.
Return vs Market: 6ZB matched the German Market which returned 0.3% over the past year.
Price Volatility
| 6ZB volatility | |
|---|---|
| 6ZB Average Weekly Movement | 3.8% |
| Capital Markets Industry Average Movement | 4.0% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.7% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: 6ZB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 6ZB's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 2 | Karl Tobieson | www.linc.se/?lang=en |
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies.
Linc AB Fundamentals Summary
| 6ZB fundamental statistics | |
|---|---|
| Market cap | €395.80m |
| Earnings (TTM) | €29.53m |
| Revenue (TTM) | €28.45m |
Is 6ZB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6ZB income statement (TTM) | |
|---|---|
| Revenue | SEK 314.89m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 314.89m |
| Other Expenses | -SEK 11.89m |
| Earnings | SEK 326.78m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.65 |
| Gross Margin | 100.00% |
| Net Profit Margin | 103.78% |
| Debt/Equity Ratio | 0% |
How did 6ZB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/22 20:52 |
| End of Day Share Price | 2026/07/22 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Linc AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.